Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation
Bruno Fattizzo(University of Milan), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Ramona Cassin(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Giorgia Levati(University of Milan)
Cited by 57
Related Papers
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|371
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
|Disease Markers|2015|281